Shenzhen - Delayed Quote CNY
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ)
11.08
+0.05
+(0.45%)
At close: 3:04:30 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
5,301,711.54
5,280,713.41
5,445,572.06
7,159,410.68
6,365,177.48
Cost of Revenue
3,638,076.17
3,524,558.25
3,645,268.75
4,825,009.75
4,332,138.40
Gross Profit
1,663,635.37
1,756,155.16
1,800,303.31
2,334,400.93
2,033,039.09
Operating Expense
1,030,491.40
1,013,647.92
1,160,308.24
1,211,852.27
1,068,874.40
Operating Income
633,143.97
742,507.24
639,995.07
1,122,548.66
964,164.69
Net Non Operating Interest Income Expense
10,125.12
-109,115.29
-199,175.03
-203,087.71
-162,846.72
Pretax Income
723,262.70
726,229.26
-928,333.83
829,850.96
222,262.94
Tax Provision
96,773.31
101,311.22
-126,174.60
114,815.76
-11,120.49
Net Income Common Stockholders
648,291.59
646,741.67
-783,258.04
727,425.65
240,787.58
Basic EPS
0.44
--
-0.53
0.50
0.16
Diluted EPS
0.44
--
-0.53
0.50
0.16
Basic Average Shares
1,467,394.57
--
1,467,324.92
1,468,063.89
1,467,322.23
Diluted Average Shares
1,467,394.57
--
1,467,324.92
1,468,063.89
1,467,322.23
Total Operating Income as Reported
723,443.58
741,310.98
-860,910.89
828,623.18
227,474.70
Total Expenses
4,668,567.57
4,538,206.17
4,805,576.99
6,036,862.03
5,401,012.79
Net Income from Continuing & Discontinued Operation
648,291.59
646,741.67
-783,258.04
727,425.65
240,787.58
Normalized Income
808,626.19
711,429.17
67,246.39
876,077.11
466,678.54
Interest Income
44,119.30
44,374.95
39,521.46
54,138.64
54,856.87
Interest Expense
118,495.08
141,184.43
223,219.34
235,242.07
201,630.99
Net Interest Income
10,125.12
-109,115.29
-199,175.03
-203,087.71
-162,846.72
EBIT
841,757.77
867,413.68
-705,114.50
1,065,093.03
423,893.92
EBITDA
841,757.77
1,198,464.86
-331,518.48
1,372,752.48
726,638.62
Reconciled Cost of Revenue
3,638,076.17
3,524,558.25
3,645,268.75
4,825,009.75
4,332,138.40
Reconciled Depreciation
--
331,051.18
373,596.02
307,659.46
302,744.70
Net Income from Continuing Operation Net Minority Interest
648,291.59
646,741.67
-783,258.04
727,425.65
240,787.58
Total Unusual Items Excluding Goodwill
-185,101.35
-75,174.59
-984,283.43
-172,520.95
-301,187.95
Total Unusual Items
-185,101.35
-75,174.59
-984,283.43
-172,520.95
-301,187.95
Normalized EBITDA
1,026,859.13
1,273,639.45
652,764.95
1,545,273.43
1,027,826.58
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-24,766.76
-10,487.09
-133,779
-23,869.50
-75,296.99
12/31/2021 - 5/6/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade